Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Effects of GABAergic Agents on Multiple Sclerosis. A Narrative Review of In-vivo Models.
CNS Neurol Disord Drug Targets. 2023;22(10):1439-1452. doi: 10.2174/1871527322666221003091444.
CNS Neurol Disord Drug Targets. 2023.
PMID: 36200199
Review.
Disease-modifying agents for multiple sclerosis and the risk for reporting cancer: A disproportionality analysis using the US Food and Drug Administration Adverse Event Reporting System database.
Stamatellos VP, Siafis S, Papazisis G.
Stamatellos VP, et al.
Br J Clin Pharmacol. 2021 Dec;87(12):4769-4779. doi: 10.1111/bcp.14916. Epub 2021 Jun 2.
Br J Clin Pharmacol. 2021.
PMID: 33998034
Free article.
Item in Clipboard
Atypical antipsychotics in multiple sclerosis: A review of their in vivo immunomodulatory effects.
Stamoula Ε, Ainatzoglou A, Stamatellos VP, Dardalas I, Siafis S, Matsas A, Stamoulas K, Papazisis G.
Stamoula Ε, et al. Among authors: stamatellos vp.
Mult Scler Relat Disord. 2022 Feb;58:103522. doi: 10.1016/j.msard.2022.103522. Epub 2022 Jan 12.
Mult Scler Relat Disord. 2022.
PMID: 35063906
Review.
Item in Clipboard
S1P receptor modulators in Multiple Sclerosis: Detecting a potential skin cancer safety signal.
Stamatellos VP, Rigas A, Stamoula E, Lallas A, Papadopoulou A, Papazisis G.
Stamatellos VP, et al.
Mult Scler Relat Disord. 2022 Mar;59:103681. doi: 10.1016/j.msard.2022.103681. Epub 2022 Feb 9.
Mult Scler Relat Disord. 2022.
PMID: 35168096
Item in Clipboard
Safety and Monitoring of the Treatment with Disease-Modifying Therapies (DMTs) for Multiple Sclerosis (MS).
Stamatellos VP, Papazisis G.
Stamatellos VP, et al.
Curr Rev Clin Exp Pharmacol. 2023;18(1):39-50. doi: 10.2174/2772432817666220412110720.
Curr Rev Clin Exp Pharmacol. 2023.
PMID: 35418296
Review.
Item in Clipboard
Weight gain, gender, and antipsychotics: a disproportionality analysis of the FDA Adverse Event Reporting System database (FAERS).
Stamoula E, Stamatellos VP, Vavilis T, Dardalas I, Papazisis G.
Stamoula E, et al. Among authors: stamatellos vp.
Expert Opin Drug Saf. 2024 Feb;23(2):239-245. doi: 10.1080/14740338.2023.2248873. Epub 2023 Aug 21.
Expert Opin Drug Saf. 2024.
PMID: 37589503
Item in Clipboard
Cite
Cite